Follicular activity in horses pertains to the cyclical development and maturation of ovarian follicles, which are structures that contain the developing eggs. This process is integral to the reproductive cycle in mares and involves various stages, including follicular growth, maturation, ovulation, and regression. The activity is regulated by a complex interplay of hormonal signals, primarily involving the hypothalamus, pituitary gland, and ovaries. Hormones such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH) play significant roles in stimulating and controlling follicular development. Understanding follicular activity is essential for managing breeding programs, diagnosing reproductive disorders, and optimizing fertility in mares. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, regulation, and implications of follicular activity in equine reproduction.
Evans MJ, Irvine CH.Heterologous radioimmunoassays were developed for equine FSH and LH. Serum concentrations were measured in twenty-three mares throughout the oestrous cycle and early pregnancy. FSH concentrations were raised fivefold by 'surges' rather than 'spiked', occurring at 10- to 11-day intervals during the oestrous cycle and early pregnancy. The late oestrous/early dioestrous surge of FSH appeared to initiate development of up to twenty follicles. The mid-dioestrous surge may be important for the further development of follicles destined to ovulate 10 to 13 days later. Levels of LH were increasing by t...
Younglai EV.The research studied the effect of follicular fluid and plasma on the steroid-producing activity of granulosa cells isolated from the ovaries of horses in heat. The results could potentially provide […]
SHORT RV.A comparison has been made between the steroids present in equine follicular fluid and luteal tissue. Follicular fluid was found to contain progesterone, 17α-hydroxyprogesterone, androstenedione, epitestosterone, 19-norandrostenedione, oestrone, oestradiol-17β and 6α-hydroxyoestradiol-17β, in confirmation of previous studies. On the other hand, luteal tissue contained large amounts of progesterone and 20α-hydroxypregn-4-en-3-one, and a small quantity of 17α-hydroxyprogesterone. No C18 or C19 steroids could be detected.
These findings are therefore interpreted as evidence in favour of ...
Khan Y, Gautier C, Aurich C, El-Shalofy A.Letrozole is a potent and highly selective third-generation aromatase inhibitor. In the present study, we aimed to investigate the effects of letrozole treatment of non-pregnant mares on estrous cycle characteristics. Cyclic, non-lactating mares (n = 9) were included. After estrus synchronization, mares were monitored to detect ovulation (d0:) of the treatment cycle. Each three mares were randomly assigned to one of three treatments: control, 0.5, and 1 mg/kg body weight letrozole in three consecutive cycles (d7 to d13 of the treatment cycle). Mares were inseminated in the estrus after trea...
Sala-Ayala L, Cuervo-Arango J, Martínez Boví R.Endometrial edema is an ultrasonographic sign of estrus in mares and is positively associated with fertility. This study aimed to evaluate the influence of follicular size, systemic progesterone (P4), and exogenous estradiol benzoate (EB) on the onset and duration of endometrial edema. In Experiment 1, anestrus (n = 4) and diestrus mares (n = 4) received 4 mg of EB intramuscularly; edema scores and plasma P4 were monitored over four days. In a complementary group (n = 5), mares were monitored until ovulation, then administered 4 mg of EB and examined every 12 h for 48 h. In Experimen...
Fresa K, Catandi GD, Gonzalez-Castro R, Omar A, Whitcomb LA, Cheng MH, Chen TW, Carnevale EM, Chicco AJ.Advancing age is associated with a decline in fertility and functional capacity, which may result in part from suboptimal nutrition and impaired mitochondrial function. Dietary essential polyunsaturated fatty acids (PUFA) are broadly recommended to mitigate weight loss and reduce risk of chronic disease in aged populations, but their effects on mitochondrial function are less clear. The present study investigated the impacts of dietary supplementation with essential omega-3 PUFA (flaxseed oil; N3) or omega-6 PUFA (corn oil, N6) on blood, muscle and follicular cell fatty acid composition and mi...
Ver Goltz L, Gomes SP, Schimming BC, Abdala FCM, Miglino MA, de Castro Sasahara TH.The equine ovary exhibits unique structural and developmental features that distinguish it from those of other domestic species, including the presence of an ovulation fossa and an inversion of cortical and medullary layers. This study aimed to investigate the morphostructural development of the equine fetal ovary, with particular emphasis on the formation of the ovulation fossa. Fourteen female equine fetuses, ranging from 70 to 200 days of gestation, were collected from a commercial abattoir. Results revealed a progressive increase in ovarian volume and marked histological changes througho...
Vaz IS, Silva MB, Maran AP, Almeida MER, Guimarães EC, Cuervo-Arango J, Silva ESM.The duration of endometrial edema has been positively correlated with uterine receptivity and likelihood of pregnancy. Therefore, this study aimed to evaluate whether there is a relationship between the duration of endometrial edema (DEdema) and other key parameters of the estrous cycle: maximum edema (MEdema), largest follicle diameter (LPF), corpus luteum and uterine tone on day 5 post ovulation (CLD5 and TD5), progesterone concentration (P4) and fertility. A total of 88 cycles from 36 mares were evaluated and divided into Short Estrus (SE), Long Estrus (LE), Inseminated (AI) and Non-insemin...
Faria LG, Zutter BM, Freitas-Dell'Aqua CP, Camillo BL, Ávila-Júnior OS, Bassetti FS, Marcolino LC, Alvarenga MA.To evaluate the effects of therapeutic and supratherapeutic periovulatory doses of firocoxib on ovulation and follicular dynamics in mares. Methods: Seventy cycling mares were randomly assigned to receive firocoxib at 0.1 mg/kg (n = 27), firocoxib at 0.3 mg/kg (n = 22), or no treatment (control; n = 21). Treatments were initiated on Day 0, defined as the day of ovulation induction with a GnRH analogue administered intramuscularly, with firocoxib administered intravenously on Day 0 and Day 1 (24 h apart). Follicular diameter and ovulation timing were assessed by transrectal ultrasonography. Res...
